Cargando…

Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms

Access to effective affordable contraception is critical for individual and public health. A wide range of hormonal contraceptives (HCs), which differ in composition, concentration of the progestin component, frequency of dosage, and method of administration, is currently available globally. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hapgood, Janet P., Kaushic, Charu, Hel, Zdenek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807094/ https://www.ncbi.nlm.nih.gov/pubmed/29309550 http://dx.doi.org/10.1210/er.2017-00103

Ejemplares similares

Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out
por: Hapgood, Janet P.
Publicado: (2020)

Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women()()
por: Heffron, Renee, et al.
Publicado: (2019)

Role of sex hormones and the vaginal microbiome in susceptibility and mucosal immunity to HIV-1 in the female genital tract
por: Vitali, Danielle, et al.
Publicado: (2017)

Hormonal contraception and HIV acquisition among women: an updated systematic review
por: Curtis, Kathryn M, et al.
Publicado: (2020)

The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women
por: Wessels, Jocelyn M., et al.
Publicado: (2018)

Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition
por: Haddad, Lisa B., et al.
Publicado: (2018)

Hormonal Contraception and the Risk of HIV Acquisition: An Individual Participant Data Meta-analysis
por: Morrison, Charles S., et al.
Publicado: (2015)

Vaginal microbiome-hormonal contraceptive interactions associate with the mucosal proteome and HIV acquisition
por: Noël-Romas, Laura, et al.
Publicado: (2020)

An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women
por: Polis, Chelsea B., et al.
Publicado: (2016)

Increased HIV‐1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms
por: Bick, Alexis J., et al.
Publicado: (2022)

The Progestin-Only Contraceptive Medroxyprogesterone Acetate, but Not Norethisterone Acetate, Enhances HIV-1 Vpr-Mediated Apoptosis in Human CD4(+) T Cells through the Glucocorticoid Receptor
por: Tomasicchio, Michele, et al.
Publicado: (2013)

Hormonal Contraception
por: Speroff, Leon
Publicado: (1973)

Hormonal Contraception
por: Kase, Nathan
Publicado: (1970)

Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?()()()
por: Smith, Jennifer A., et al.
Publicado: (2017)

The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations
por: Ray, Roslyn M., et al.
Publicado: (2019)

Non-Hormonal Contraception
por: Howard, Sarah Anne, et al.
Publicado: (2023)

Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy
por: Robinson, Jennifer A., et al.
Publicado: (2012)

Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract
por: Dizzell, Sara, et al.
Publicado: (2019)

Non-Contraceptive Benefits of Oral Hormonal Contraceptives
por: Schindler, Adolf E
Publicado: (2012)

Lactic acid enhances vaginal epithelial barrier integrity and ameliorates inflammatory effects of dysbiotic short chain fatty acids and HIV-1
por: Schwecht, Ingrid, et al.
Publicado: (2023)

Advances in Humanized Mouse Models to Improve Understanding of HIV-1 Pathogenesis and Immune Responses
por: Gillgrass, Amy, et al.
Publicado: (2021)

Update on male hormonal contraception
por: Gava, Giulia, et al.
Publicado: (2019)

Hormonal Contraception and HIV/AIDS Transmission: Challenges for Zimbabwe’s Reproductive Health Service Providers in Promoting Informed Contraception Choices
por: Mafuva, Christopher, et al.
Publicado: (2013)

Recent advances in hormonal contraception
por: Li, HW Raymond, et al.
Publicado: (2010)

Advances in male hormonal contraception
por: Antonietta, Costantino, et al.
Publicado: (2014)

The Anti-Inflammatory Activity of Curcumin Protects the Genital Mucosal Epithelial Barrier from Disruption and Blocks Replication of HIV-1 and HSV-2
por: Ferreira, Victor H., et al.
Publicado: (2015)

Hormonal contraceptive use in HIV-infected women using antiretroviral therapy: a systematic review
por: Womack, Julie A, et al.
Publicado: (2015)

Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?
por: Nappi, Rossella E, et al.
Publicado: (2013)

Influence of Hormonal Contraceptive Use and HIV on Cervicovaginal Cytokines and Microbiota in Malawi
por: Haddad, Lisa B., et al.
Publicado: (2023)

Venous thrombosis and hormonal contraception: what’s new with estradiol-based hormonal contraceptives?
por: Fruzzetti, Franca, et al.
Publicado: (2018)

Contraception and HIV infection in women
por: Heikinheimo, Oskari, et al.
Publicado: (2009)

Clinical Pharmacology of Hormonal Emergency Contraceptive Pills
por: Matyanga, Celia M. J., et al.
Publicado: (2018)

The Potential of Hormonal Contraception to Influence Female Sexuality
por: de Castro Coelho, Filipa, et al.
Publicado: (2019)

Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
por: Bowers, Nathan L., et al.
Publicado: (2014)

Mechanisms of action of currently available woman-controlled, vaginally administered, non-hormonal contraceptive products
por: Chappell, B. Todd, et al.
Publicado: (2022)

Hormonal contraception, sexual behaviour and HIV prevalence among women in Cameroon
por: Kongnyuy, Eugene J, et al.
Publicado: (2008)

The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor
por: Tomasicchio, Michele, et al.
Publicado: (2019)

Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial
por: Singata-Madliki, Mandisa, et al.
Publicado: (2021)

Effects of Female Sex Hormones on Susceptibility to HSV-2 in Vaginal Cells Grown in Air-Liquid Interface
por: Lee, Yung, et al.
Publicado: (2016)

The Injectable-Only Contraceptive Medroxyprogesterone Acetate, Unlike Norethisterone Acetate and Progesterone, Regulates Inflammatory Genes in Endocervical Cells via the Glucocorticoid Receptor
por: Govender, Yashini, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_bbj2ie6cfbm96ni5nhsvccm71v